PT1673359E - Processo para a preparação de formas cristalinas de orlistat - Google Patents
Processo para a preparação de formas cristalinas de orlistat Download PDFInfo
- Publication number
- PT1673359E PT1673359E PT04769349T PT04769349T PT1673359E PT 1673359 E PT1673359 E PT 1673359E PT 04769349 T PT04769349 T PT 04769349T PT 04769349 T PT04769349 T PT 04769349T PT 1673359 E PT1673359 E PT 1673359E
- Authority
- PT
- Portugal
- Prior art keywords
- orlistat
- crystalline forms
- preparation
- relates
- processes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C07D305/12—Beta-lactones
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1144DE2003 | 2003-09-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1673359E true PT1673359E (pt) | 2009-10-06 |
Family
ID=34308043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT04769349T PT1673359E (pt) | 2003-09-12 | 2004-09-13 | Processo para a preparação de formas cristalinas de orlistat |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1673359B1 (pt) |
AT (1) | ATE442361T1 (pt) |
DE (1) | DE602004023102D1 (pt) |
ES (1) | ES2329474T3 (pt) |
PT (1) | PT1673359E (pt) |
WO (1) | WO2005026140A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1763021B (zh) * | 2005-09-29 | 2010-08-11 | 杭州华东医药集团生物工程研究所有限公司 | 一种提纯奥利司他的方法 |
EP1803714A1 (en) * | 2005-12-27 | 2007-07-04 | KRKA, tovarna zdravil, d.d., Novo mesto | Process for preparing crystalline forms of orlistat |
EP1944025A1 (en) * | 2007-01-09 | 2008-07-16 | Ranbaxy Laboratories Limited | Stable pharmaceutical compositions of orlistat |
PL2002825T3 (pl) * | 2007-06-14 | 2013-12-31 | Krka | Kompozycje farmaceutyczne zawierające orlistat |
EP2141236A1 (en) | 2008-07-03 | 2010-01-06 | KRKA, D.D., Novo Mesto | Process for production of lipstatin and microorganisms therefore |
US8309107B2 (en) | 2008-10-06 | 2012-11-13 | Banner Pharmacaps, Inc. | Stable solutions of orlistat for pharmaceutical dosage forms |
EP2389370A4 (en) * | 2009-01-22 | 2012-09-05 | Biocon Ltd | CRYSTALLINE FORM OF ORLISTAT AND METHOD THEREFOR |
SI2413911T1 (sl) | 2009-03-31 | 2014-04-30 | Krka, D.D., Novo Mesto | Progresivna emulzijska kristalizacija |
CN102993135B (zh) * | 2012-12-31 | 2015-09-09 | 山东新时代药业有限公司 | 一种奥利司他的纯化方法 |
CN107266395A (zh) * | 2017-08-08 | 2017-10-20 | 中山万远新药研发有限公司 | 一种奥利司他ⅰ晶型的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1028115T3 (da) * | 1999-01-29 | 2003-03-17 | Hoffmann La Roche | Oprensning af lipstatin |
US6730319B2 (en) * | 2001-06-06 | 2004-05-04 | Hoffmann-La Roche Inc. | Pharmaceutical compositions having depressed melting points |
EP1470116A4 (en) * | 2001-12-04 | 2005-04-06 | Biogal Gyogyszergyar | PREPARATION OF THE ORLISTAT AND CRYSTALLINE FORMS OF THE ORLISTAT |
-
2004
- 2004-09-13 ES ES04769349T patent/ES2329474T3/es active Active
- 2004-09-13 AT AT04769349T patent/ATE442361T1/de not_active IP Right Cessation
- 2004-09-13 PT PT04769349T patent/PT1673359E/pt unknown
- 2004-09-13 WO PCT/IB2004/002957 patent/WO2005026140A1/en active Application Filing
- 2004-09-13 DE DE602004023102T patent/DE602004023102D1/de active Active
- 2004-09-13 EP EP04769349A patent/EP1673359B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP1673359A1 (en) | 2006-06-28 |
EP1673359B1 (en) | 2009-09-09 |
ES2329474T3 (es) | 2009-11-26 |
DE602004023102D1 (de) | 2009-10-22 |
ATE442361T1 (de) | 2009-09-15 |
WO2005026140A1 (en) | 2005-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05004247A (es) | Cromonas y derivados de cromona y usos de los mismos. | |
MXPA05012061A (es) | Preparacion y uso de derivados alquilarilo para el tratamiento de la obesidad. | |
WO2004062625A3 (en) | Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease | |
MY134783A (en) | Rho-kinase inhibitors | |
MY142915A (en) | Rho-kinase inhibitors | |
WO2005004803A3 (en) | Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease | |
WO2006034154A3 (en) | Salts of 5-azacytidine | |
IL147271A0 (en) | Compounds that bind her2 | |
MY145077A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
ZA200709535B (en) | Methods and compositions for the treatment of CNS-related conditions | |
WO2005018545A3 (en) | Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease | |
HK1069169A1 (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
TW200504034A (en) | Therapeutic agents | |
MY138851A (en) | Quinazoline derivatives | |
TW200628473A (en) | Novel heterocycles | |
MXPA05007462A (es) | Derivados de pirrolopiridazina. | |
EP1817312A4 (en) | MACROCYCLIC AMINIOPYRIDYL BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER | |
GB0102672D0 (en) | Compounds | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
PT1673359E (pt) | Processo para a preparação de formas cristalinas de orlistat | |
IL160171A0 (en) | Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
MXPA04000531A (es) | Acilsemicarbazidas como inhibidores de cinasa dependiente de ciclina utiles como agentes anti-cancer y anti-proliferativos. | |
ATE399758T1 (de) | Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten | |
SI1606288T1 (sl) | Derivati benzensulfonamida, postopek za njihovo pripravo in njihova uporaba za zdravljenje bolečine | |
WO2004073375A3 (en) | Podophyllotoxin derivatives as antitumor agents |